Cyclosporine acts by decreasing the production of:
## **Core Concept**
Cyclosporine is an immunosuppressive medication primarily used to prevent organ rejection in transplant patients and to treat certain autoimmune diseases. It acts by inhibiting the immune response, specifically targeting T-lymphocytes. The drug works through a unique mechanism involving the inhibition of calcineurin, which is crucial for the activation of T-cells.
## **Why the Correct Answer is Right**
Cyclosporine exerts its immunosuppressive effects by binding to cyclophilin, a protein in T-lymphocytes. This complex then inhibits **calcineurin**, a phosphatase enzyme that is necessary for the dephosphorylation and subsequent translocation of **NFAT (Nuclear Factor of Activated T-cells)** into the nucleus. NFAT is essential for the transcription of the gene encoding **IL-2 (Interleukin-2)**, a critical cytokine involved in the proliferation of T-cells. By preventing IL-2 production, cyclosporine effectively reduces T-cell activation and proliferation, thereby decreasing the immune response.
## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because cyclosporine's primary mechanism does not involve directly decreasing the production of prostaglandins, which are more related to the action of non-steroidal anti-inflammatory drugs (NSAIDs).
- **Option B:** This option is incorrect as cyclosporine does not primarily act by decreasing the production of interferons, although it may indirectly affect various cytokines.
- **Option D:** This option is incorrect because cyclosporine's mechanism is not directly related to the inhibition of tumor necrosis factor-alpha (TNF-alpha) production, which is a target for other classes of immunosuppressive drugs.
## **Clinical Pearl / High-Yield Fact**
A key clinical consideration with cyclosporine is its potential for nephrotoxicity and hypertension as side effects, which necessitates careful monitoring of renal function and blood pressure in patients on this medication. Additionally, cyclosporine levels must be monitored to ensure they remain within a therapeutic range, as levels that are too high increase the risk of toxicity, while levels that are too low may lead to inadequate immunosuppression.
## **Correct Answer:** C. IL-2.